The family of K2P channels: Salient structural and functional properties

Journal of Physiology

Volumn 593, Issue 12, 2015, Pages 2587-2603

  Feliciangeli, Sylvain ^a   Chatelain, Frank C ^a   Bichet, Delphine ^a   Lesage, Florian ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; POTASSIUM CHANNEL; PROTEIN TWIK1; TWIK RELATED ACID POTASSIUM CHANNEL; TWIK RELATED ACID POTASSIUM CHANNEL 1; TWIK RELATED ACID POTASSIUM CHANNEL 3; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; PROTEIN SUBUNIT; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

ELECTROPHYSIOLOGY; GENETIC DISORDER; HUMAN; MISSENSE MUTATION; NONHUMAN; PATHOPHYSIOLOGY; PH; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN SUBUNIT;

ANIMALS; HUMANS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PROTEIN SUBUNITS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84931569110     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.287268     Document Type: Review

References (192)

1. Aller MI, Veale EL, Linden A-M, Sandu C, Schwaninger M, Evans LJ, Korpi ER, Mathie A, Wisden W & Brickley SG (2005). Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons. J Neurosci 25, 11455-11467.
2. + channel involved in polymodal pain perception. EMBO J 25, 2368-2376.
3. Alvarez-Baron CP, Jonsson P, Thomas C, Dryer SE & Williams C (2011). The two-pore domain potassium channel KCNK5: induction by estrogen receptor α and role in proliferation of breast cancer cells. Mol Endocrinol 25, 1326-1336.
4. 2P potassium channel TASK-2: a role of basic residues in the C terminus domain. Pflugers Arch 465, 1715-1726.
5. Aryal P, Abd-Wahab F, Bucci G, Sansom MSP & Tucker SJ (2014). A hydrophobic barrier deep within the inner pore of the TWIK-1 K2P potassium channel. Nat Commun 5, 4377.
6. + channel family. Pflugers Arch 442, 828-833.
7. + channel TREK-1 protein. Biochem Biophys Res Commun 346, 108-115.
8. 2P channels. ACS Chem Biol 8, 1841-1851.
9. 2P2.1 (TREK-1) through modular sensory and gating domains. EMBO J 31, 3297-3308.
10. 2P channel function. EMBO J 30, 3594-3606.
11. Bando Y, Hirano T & Tagawa Y (2014). Dysfunction of KCNK potassium channels impairs neuronal migration in the developing mouse cerebral cortex. Cereb Cortex 24, 1017-1029.
12. + channel family. J Biol Chem 275, 17412-17419.
13. Barel O, Shalev SA, Ofir R, Cohen A, Zlotogora J, Shorer Z, Mazor G, Finer G, Khateeb S, Zilberberg N & Birk OS (2008). Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9. Am J Hum Genet 83, 193-199.
14. Barriere H, Belfodil R, Rubera I, Tauc M, Lesage F, Poujeol C, Guy N, Barhanin J & Poujeol P (2003). Role of TASK2 potassium channels regarding volume regulation in primary cultures of mouse proximal tubules. J Gen Physiol 122, 177-190.
15. Bautista DM, Sigal YM, Milstein AD, Garrison JL, Zorn JA, Tsuruda PR, Nicoll RA & Julius D (2008). Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels. Nat Neurosci 11, 772-779.
16. Bayliss DA & Barrett PQ (2008). Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. Trends Pharmacol Sci 29, 566-575.
17. Beitzinger M, Hofmann L, Oswald C, Beinoraviciute-Kellner R, Sauer M, Griesmann H, Bretz AC, Burek C, Rosenwald A & Stiewe T (2008). p73 poses a barrier to malignant transformation by limiting anchorage-independent growth. EMBO J 27, 792-803.
18. + (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J Neurosci 24, 6693-6702.
19. Bichet D, Blin S, Feliciangeli S, Chatelain FC, Bobak N & Lesage F (2015). Silent but not dumb: how cellular trafficking and pore gating modulate expression of TWIK1 and THIK2. Pflugers Arch; in press.
20. Bittner S, Meuth SG, Göbel K, Melzer N, Herrmann AM, Simon OJ, Weishaupt A, Budde T, Bayliss DA, Bendszus M & Wiendl H (2009). TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system. Brain 132, 2501-2516.
21. Bittner S, Ruck T, Fernández-Orth J & Meuth SG (2014). TREK-king the blood-brain-barrier. J Neuroimmune Pharmacol 9, 293-301.
22. Bittner S, Ruck T, Schuhmann MK, Herrmann AM, Moha ou Maati H, Bobak N, Göbel K, Langhauser F, Stegner D, Ehling P, Borsotto M, Pape H-C, Nieswandt B, Kleinschnitz C, Heurteaux C, Galla H-J, Budde T, Wiendl H & Meuth SG (2013). Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med 19, 1161-1165.
23. + channel subunits THIK1 and THIK2 assemble and form active channels. J Biol Chem 289, 28202-28212.
24. Blondeau N, Pétrault O, Manta S, Giordanengo V, Gounon P, Bordet R, Lazdunski M & Heurteaux C (2007). Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 101, 176-184.
25. Bobak N, Bittner S, Andronic J, Hartmann S, Mühlpfordt F, Schneider-Hohendorf T, Wolf K, Schmelter C, Göbel K, Meuth P, Zimmermann H, Döring F, Wischmeyer E, Budde T, Wiendl H, Meuth SG & Sukhorukov VL (2011). Volume regulation of murine T lymphocytes relies on voltage-dependent and two-pore domain potassium channels. Biochim Biophys Acta 1808, 2036-2044.
26. Bockenhauer D, Zilberberg N & Goldstein SAN (2001). KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat Neurosci 4, 486-491.
27. + channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutical concept. Br J Pharmacol 172, 771-784.
28. Brickley SG, Revilla V, Cull-Candy SG, Wisden W & Farrant M (2001). Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409, 88-92.
29. + ion channel. Science 335, 436-441.
30. + channels. Proc Natl Acad Sci U S A 111, 3614-3619.
31. Buckler KJ, Williams BA & Honore E (2000). An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells. J Physiol 525, 135-142.
32. + channels mediate inhibition of orexin neurons by glucose. Neuron 50, 711-722.
33. + channels heterologously expressed in human embryonic kidney cells. Neuroscience 135, 1087-1094.
34. Chae YJ, Zhang J, Au P, Sabbadini M, Xie G-X & Yost CS (2010). Discrete change in volatile anesthetic sensitivity in mice with inactivated tandem pore potassium ion channel TRESK. Anesthesiology 113, 1326-1337.
35. Chatelain FC, Bichet D, Douguet D, Feliciangeli S, Bendahhou S, Reichold M, Warth R, Barhanin J & Lesage F (2012). TWIK1, a unique background channel with variable ion selectivity. Proc Natl Acad Sci U S A 109, 5499-5504.
36. + channel 2 (THIK2) relies on combined intracellular retention and low intrinsic activity at the plasma membrane. J Biol Chem 288, 35081-35092.
37. Chavez RA, Gray AT, Zhao BB, Kindler CH, Mazurek MJ, Mehta Y, Forsayeth Jr. & Yost CS (1999). TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family. J Biol Chem 274, 7887-7892.
38. + channels in cell development and excitability. Trends Pharmacol Sci 35, 461-469.
39. Chen X, Talley EM, Patel N, Gomis A, McIntire WE, Dong B, Viana F, Garrison JC & Bayliss DA (2006). Inhibition of a background potassium channel by Gq protein α-subunits. Proc Natl Acad Sci U S A 103, 3422-3427.
40. 2P2.1 channel gating facilitation of C-type gating by protonation of extracellular histidine residues. J Biol Chem 283, 19448-19455.
41. Comoglio Y, Levitz J, Kienzler MA, Lesage F, Isacoff EY & Sandoz G (2014). Phospholipase D2 specifically regulates TREK potassium channels via direct interaction and local production of phosphatidic acid. Proc Natl Acad Sci U S A 111, 13547-13552.
42. Czirják G & Enyedi P (2002a). Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem 277, 5426-5432.
43. Czirják G & Enyedi P (2002b). TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol 16, 621-629.
44. + channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II. Mol Endocrinol 14, 863-874.
45. + channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin. J Biol Chem 279, 18550-18558.
46. Czirják G, Vuity D & Enyedi P (2008). Phosphorylation-dependent binding of 14-3-3 proteins controls TRESK regulation. J Biol Chem 283, 15672-15680.
47. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA & Barrett PQ (2008). TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci U S A 105, 2203-2208.
48. Decher N, Wemhöner K, Rinné S, Netter MF, Zuzarte M, Aller MI, Kaufmann SG, Li XT, Meuth SG, Daut J, Sachse FB & Maier SKG (2011). Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex. Cell Physiol Biochem 28, 77-86.
49. + channel with EFA6, a GDP/GTP exchange factor for ARF6. EMBO Rep 5, 1171-1175.
50. + channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones. J Physiol 585, 867-879.
51. Donner BC, Schullenberg M, Geduldig N, Hüning A, Mersmann J, Zacharowski K, Kovacevic A, Decking U, Aller MI & Schmidt KG (2011). Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability. Basic Res Cardiol 106, 75-87.
52. + conduction and selectivity. Science 280, 69-77.
53. + channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species. J Physiol 562, 235-244.
54. + channel to sense external pH variations near physiological pH. EMBO J 16, 5464-5471.
55. + channels TREK-1 and TRAAK. Mol Pharmacol 57, 906-912.
56. + channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells. Am J Physiol Endocrinol Metab 287, E1154-E1165.
57. Enyedi P, Braun G & Czirják G (2012). TRESK: the lone ranger of two-pore domain potassium channels. Mol Cell Endocrinol 353, 75-81.
58. + currents: two-pore domain potassium channels. Physiol Rev 90, 559-605.
59. + channel in vitro. PloS One 9, e97854.
60. Es-Salah-Lamoureux Z, Steele DF & Fedida D (2010). Research into the therapeutic roles of two-pore-domain potassium channels. Trends Pharmacol Sci 31, 587-595.
61. + channels? Cell 130, 563-569.
62. Feliciangeli S, Tardy MP, Sandoz G, Chatelain FC, Warth R, Barhanin J, Bendahhou S & Lesage F (2010). Potassium channel silencing by constitutive endocytosis and intracellular sequestration. J Biol Chem 285, 4798-4805.
63. + channel. EMBO J 15, 6854-6862.
64. + channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 17, 3297-3308.
65. Fong P, Argent BE, Guggino WB & Gray MA (2003). Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF. Am J Physiol Cell Physiol 285, C433-C445.
66. + current. Nature 333, 662-664.
67. Friedrich C, Rinné S, Zumhagen S, Kiper AK, Silbernagel N, Netter MF, Stallmeyer B, Schulze-Bahr E & Decher N (2014). Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder. EMBO Mol Med 6, 937-951.
68. Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, Guy N, Heurteaux C, Lazdunski M & Saumet JL (2007). Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep 8, 354-359.
69. Gerstin KM, Gong DH, Abdallah M, Winegar BD, Eger EI & Gray AT (2003). Mutation of KCNK5 or Kir3.2 potassium channels in mice does not change minimum alveolar anesthetic concentration. Anesth Analg 96, 1345-1349, table of contents.
70. 2 sensitivity. Proc Natl Acad Sci U S A 107, 2325-2330.
71. + channels. Biochem Biophys Res Commun 282, 249-256.
72. + channel, TASK-1. EMBO J 21, 4439-4448.
73. Goldstein SAN, Bayliss DA, Kim D, Lesage F, Plant LD & Rajan S (2005). International union of pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 57, 527-540.
74. + channels: function-structural overview. Compr Physiol 2, 2087-2149.
75. González JA, Jensen LT, Doyle SE, Miranda-Anaya M, Menaker M, Fugger L, Bayliss DA & Burdakov D (2009). Deletion of TASK1 and TASK3 channels disrupts intrinsic excitability but does not abolish glucose or pH responses of orexin/hypocretin neurons. Eur J Neurosci 30, 57-64.
76. Gotter AL, Santarelli VP, Doran SM, Tannenbaum PL, Kraus RL, Rosahl TW, Meziane H, Montial M, Reiss DR, Wessner K, McCampbell A, Stevens J, Brunner JI, Fox SV, Uebele VN, Bayliss DA, Winrow CJ & Renger JJ (2011). TASK-3 as a potential antidepressant target. Brain Res 1416, 69-79.
77. + channels TREK-1 and TASK-3 are differentially modulated by copper and zinc. Mol Pharmacol 66, 530-537.
78. Gu W, Schlichthörl G, Hirsch JR, Engels H, Karschin C, Karschin A, Derst C, Steinlein OK & Daut J (2002). Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J Physiol 539, 657-668.
79. Guagliardo NA, Yao J, Hu C, Schertz EM, Tyson DA, Carey RM, Bayliss DA & Barrett PQ (2012). TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension 59, 999-1005.
80. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ & Kempsill FEJ (2003). Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 93, 957-964.
81. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stühmer W & Wang X (2005). International union of pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 57, 473-508.
82. + channels. J Neurosci 29, 2528-2533.
83. + channel. J Biol Chem 276, 26499-26508.
84. Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A, Lalli E, Guy N, Mengual R, Reichold M, Tegtmeier I, Bendahhou S, Gomez-Sanchez CE, Aller MI, Wisden W, Weber A, Lesage F, Warth R & Barhanin J (2008). Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J 27, 179-187.
85. + channel involved in neuroprotection and general anesthesia. EMBO J 23, 2684-2695.
86. Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng X-D, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois J-M, Debonnel G & Lazdunski M (2006). Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9, 1134-1141.
87. + channel TREK-1. EMBO J 21, 2968-2976.
88. Hwang EM, Kim E, Yarishkin O, Woo DH, Han K-S, Park N, Bae Y, Woo J, Kim D, Park M, Lee CJ & Park J-Y (2014). A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive conductance in astrocytes. Nat Commun 5, 3227.
89. Kang D, Choe C, Cavanaugh E & Kim D (2007). Properties of single two-pore domain TREK-2 channels expressed in mammalian cells. J Physiol 583, 57-69.
90. + channels TREK-2 and TRAAK. J Physiol 564, 103-116.
91. 3 muscarinic receptor. Am J Physiol Cell Physiol 291, C649-C656.
92. + channels of the TALK family. Biochem Biophys Res Commun 315, 836-844.
93. Kang D, Kim E-J & Han J (2012). Direct inhibitory effect of fluoxetine on TREK-2 channel. Biophys J 102, 680a.
94. 2 in the control of neuronal excitability? J Cell Mol Med 8, 38-44.
95. Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL & Mathie A (2005). Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol 144, 821-829.
96. + channels by pressure, free fatty acids and alkali. Pflugers Arch 442, 64-72.
97. + channel family. J Biol Chem 275, 9340-9347.
98. + channel in rat carotid body glomus cells. J Physiol 587, 2963-2975.
99. + channel family. Biochem Biophys Res Commun 284, 923-930.
100. i. Pflugers Arch 442, 952-960.
101. Kim E, Hwang EM, Yarishkin O, Yoo JC, Kim D, Park N, Cho M, Lee YS, Sun C-H, Yi G-S, Yoo J, Kang D, Han J, Hong S-G & Park J-Y (2010). Enhancement of TREK1 channel surface expression by protein-protein interaction with β-COP. Biochem Biophys Res Commun 395, 244-250.
102. + channels in cultured rat neuronal cells. J Physiol 484, 643-660.
103. Koh SD, Monaghan K, Sergeant GP, Ro S, Walker RL, Sanders KM & Horowitz B (2001). TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission. J Biol Chem 276, 44338-44346.
104. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S & Vandenberg CA (2005). International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 57, 509-526.
105. Lafrenière RG, Cader MZ, Poulin J-F, Andres-Enguix I, Simoneau M, Gupta N, Boisvert K, Lafrenière F, McLaughlan S, Dubé M-P, Marcinkiewicz MM, Ramagopalan S, Ansorge O, Brais B, Sequeiros J, Pereira-Monteiro JM, Griffiths LR, Tucker SJ, Ebers G & Rouleau GA (2010). A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16, 1157-1160.
106. Laigle C, Confort-Gouny S, Le Fur Y, Cozzone PJ & Viola A (2012). Deletion of TRAAK potassium channel affects brain metabolism and protects against ischemia. PLoS One 7, e53266.
107. 2P channel TREK-1 and the actin cytoskeleton. EMBO Rep 6, 642-648.
108. + channels. J Biol Chem 278, 32068-32076.
109. 2P channels. Physiology (Bethesda) 26, 424-437.
110. + channel with a novel structure. EMBO J 15, 1004-1011.
111. + channel. FEBS Lett 471, 137-140.
112. + channel subunits via a disulfide bridge. EMBO J 15, 6400-6407.
113. q protein-coupled receptors. J Biol Chem 275, 28398-28405.
114. - exchanger is crucial for TASK2 activation by hypotonic shock in proximal cell lines from mouse kidney. Am J Physiol Renal Physiol 292, F628-F638.
115. Li XT, Dyachenko V, Zuzarte M, Putzke C, Preisig-Müller R, Isenberg G & Daut J (2006). The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle. Cardiovasc Res 69, 86-97.
116. Liang B, Soka M, Christensen AH, Olesen MS, Larsen AP, Knop FK, Wang F, Nielsen JB, Andersen MN, Humphreys D, Mann SA, Huttner IG, Vandenberg JI, Svendsen JH, Haunsø S, Preiss T, Seebohm G, Olesen S-P, Schmitt N & Fatkin D (2014). Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis. J Mol Cell Cardiol 67, 69-76.
117. 2 adrenergic sedative dexmedetomidine, and cannabinoid agonists. J Pharmacol Exp Ther 317, 615-626.
118. Linden A-M, Sandu C, Aller MI, Vekovischeva OY, Rosenberg PH, Wisden W & Korpi ER (2007). TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics. J Pharmacol Exp Ther 323, 924-934.
119. Liu C, Au JD, Zou HL, Cotten JF & Yost CS (2004). Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics. Anesth Analg 99, 1715-1722, table of contents.
120. 2P6.1 produces vascular dysfunction and hypertension in mice. Hypertension 58, 672-678.
121. Lopes CMB, Gallagher PG, Buck ME, Butler MH & Goldstein SAN (2000). Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3. J Biol Chem 275, 16969-16978.
122. + channels. J Physiol 564, 117-129.
123. Lotshaw DP (2006). Biophysical and pharmacological characteristics of native two-pore domain TASK channels in rat adrenal glomerulosa cells. J Membr Biol 210, 51-70.
124. Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët D-A, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS & Chung WK (2013). A novel channelopathy in pulmonary arterial hypertension. N Engl J Med 369, 351-361.
125. Ma L, Zhang X & Chen H (2011). TWIK-1 two-pore domain potassium channels change ion selectivity and conduct inward leak sodium currents in hypokalemia. Sci Signal 4, ra37.
126. Ma L, Zhang X, Zhou M & Chen H (2012). Acid-sensitive TWIK and TASK two-pore domain potassium channels change ion selectivity and become permeable to sodium in extracellular acidification. J Biol Chem 287, 37145-37153.
127. Maher BH, Taylor M, Stuart S, Okolicsanyi RK, Roy B, Sutherland HG, Haupt LM & Griffiths LR (2013). Analysis of 3 common polymorphisms in the KCNK18 gene in an Australian migraine case-control cohort. Gene 528, 343-346.
128. + channel. J Biol Chem 274, 1381-1387.
129. + channel. EMBO J 19, 2483-2491.
130. Maingret F, Patel AJ, Lesage F, Lazdunski M & Honoré E (1999b). Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem 274, 26691-26696.
131. + channels TREK-1 and TRAAK. J Biol Chem 275, 10128-10133.
132. Mathie A, Al-Moubarak E & Veale EL (2010). Gating of two pore domain potassium channels. J Physiol 588, 3149-3156.
133. Mazella J, Pétrault O, Lucas G, Deval E, Béraud-Dufour S, Gandin C, El-Yacoubi M, Widmann C, Guyon A, Chevet E, Taouji S, Conductier G, Corinus A, Coppola T, Gobbi G, Nahon J-L, Heurteaux C & Borsotto M (2010). Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol 8, e1000355.
134. Meadows HJ & Randall AD (2001). Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel. Neuropharmacology 40, 551-559.
135. Millar ID, Taylor HC, Cooper GJ, Kibble JD, Barhanin J & Robson L (2006). Adaptive downregulation of a quinidine-sensitive cation conductance in renal principal cells of TWIK-1 knockout mice. Pflugers Arch 453, 107-116.
136. Miller AN & Long SB (2012). Crystal structure of the human two-pore domain potassium channel K2P1. Science 335, 432-436.
137. Moha Ou Maati H, Veyssiere J, Labbal F, Coppola T, Gandin C, Widmann C, Mazella J, Heurteaux C & Borsotto M (2012). Spadin as a new antidepressant: absence of TREK-1-related side effects. Neuropharmacology 62, 278-288.
138. + channels TASK-1 and -2. Pflugers Arch 445, 577-583.
139. Mu D, Chen L, Zhang X, See L-H, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KCQ, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, McCombie WR, Wigler MH & Powers S (2003). Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3, 297-302.
140. Mulkey DK, Talley EM, Stornetta RL, Siegel AR, West GH, Chen X, Sen N, Mistry AM, Guyenet PG & Bayliss DA (2007). TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J Neurosci 27, 14049-14058.
141. Murbartián J, Lei Q, Sando JJ & Bayliss DA (2005). Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels. J Biol Chem 280, 30175-30184.
142. Nie X, Arrighi I, Kaissling B, Pfaff I, Mann J, Barhanin J & Vallon V (2005). Expression and insights on function of potassium channel TWIK-1 in mouse kidney. Pflugers Arch 451, 479-488.
143. 2P potassium channel TASK-2 by intra- and extracellular pH. J Biol Chem 285, 16467-16475.
144. + channels by extracellular pH. Biochem Soc Trans 34, 899-902.
145. + channel. Proc Natl Acad Sci U S A 104, 666-671.
146. Noël J, Sandoz G & Lesage F (2011). Molecular regulations governing TREK and TRAAK channel functions. Channels (Austin) 5, 402-409.
147. + channels TRAAK and TREK-1 control both warm and cold perception. EMBO J 28, 1308-1318.
148. Nogueira EF, Gerry D, Mantero F, Mariniello B & Rainey WE (2010). The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol (Oxf) 73, 22-29.
149. O'Kelly I, Butler MH, Zilberberg N & Goldstein SAN (2002). Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 111, 577-588.
150. + channel gene KCNK4. Chromosomal localization, tissue distribution and functional expression. Brain Res Mol Brain Res 102, 18-27.
151. Pandit LM, Lloyd EE, Reynolds JO, Lawrence WS, Reynolds C, Wehrens XHT & Bryan RM (2014). TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process. Hypertension 64, 1260-1265.
152. + channels. Nat Neurosci 2, 422-426.
153. + channel. EMBO J 17, 4283-4290.
154. + channel. J Biol Chem 275, 28722-28730.
155. + channel function. Proc Natl Acad Sci U S A 100, 7803-7807.
156. Penton D, Bandulik S, Schweda F, Haubs S, Tauber P, Reichold M, Cong LD, El Wakil A, Budde T, Lesage F, Lalli E, Zennaro M-C, Warth R & Barhanin J (2012). Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension. Endocrinology 153, 4740-4748.
157. Pereira V, Busserolles J, Christin M, Devilliers M, Poupon L, Legha W, Alloui A, Aissouni Y, Bourinet E, Lesage F, Eschalier A, Lazdunski M & Noël J (2014). Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception. Pain 155, 2534-2544.
158. Piechotta PL, Rapedius M, Stansfeld PJ, Bollepalli MK, Erhlich G, Andres-Enguix I, Fritzenschaft H, Decher N, Sansom MSP, Tucker SJ & Baukrowitz T (2011). The pore structure and gating mechanism of K2P channels. EMBO J 30, 3607-3619.
159. Plant LD, Zuniga L, Araki D, Marks JD & Goldstein SAN (2012). SUMOylation silences heterodimeric TASK potassium channels containing K2P1 subunits in cerebellar granule neurons. Sci Signal 5, ra84.
160. + channel principal subunit. FEBS Lett 450, 191-196.
161. Premkumar LS, Gage PW & Chung S-H (1990). Coupled potassium channels induced by arachidonic acid in cultured neurons. Proc R Soc Lond B Biol Sci 242, 17-22.
162. + channels. Br J Pharmacol 166, 764-773.
163. + channel K2P1. Cell 121, 37-47.
164. + channels. J Biol Chem 276, 7302-7311.
165. + channel. An extracellular histiding as pH sensor. J Biol Chem 275, 16650-16657.
166. Renigunta V, Fischer T, Zuzarte M, Kling S, Zou X, Siebert K, Limberg MM, Rinné S, Decher N, Schlichthörl G & Daut J (2014a). Cooperative endocytosis of the endosomal SNARE protein syntaxin-8 and the potassium channel TASK-1. Mol Biol Cell 25, 1877-1891.
167. Renigunta V, Yuan H, Zuzarte M, Rinné S, Koch A, Wischmeyer E, Schlichthörl G, Gao Y, Karschin A, Jacob R, Schwappach B, Daut J & Preisig-Müller R (2006). The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1. Traffic 7, 168-181.
168. Renigunta V, Zou X, Kling S, Schlichthörl G & Daut J (2014b). Breaking the silence: functional expression of the two-pore-domain potassium channel THIK-2. Pflugers Arch 466, 1735-1745.
169. + channel from human kidney. J Biol Chem 273, 30863-30869.
170. Rinné S, Renigunta V, Schlichthörl G, Zuzarte M, Bittner S, Meuth SG, Decher N, Daut J & Preisig-Müller R (2014). A splice variant of the two-pore domain potassium channel TREK-1 with only one pore domain reduces the surface expression of full-length TREK-1 channels. Pflugers Arch 466, 1559-1570.
171. Rodrigues N, Bennis K, Vivier D, Pereira V, Chatelain FC, Chapuy E, Deokar H, Busserolles J, Lesage F, Eschalier A & Ducki S (2014). Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel. Eur J Med Chem 75, 391-402.
172. 2P knockout mice. J Mol Biol 385, 1331-1344.
173. Sackin H (1995). Mechanosensitive channels. Annu Rev Physiol 57, 333-353.
174. Salinas M, Reyes R, Lesage F, Fosset M, Heurteaux C, Romey G & Lazdunski M (1999). Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure. J Biol Chem 274, 11751-11760.
175. Sandoz G, Douguet D, Chatelain F, Lazdunski M & Lesage F (2009). Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue. Proc Natl Acad Sci U S A 106, 14628-14633.
176. + channel expression and trafficking. J Neurosci 28, 8545-8552.
177. + channels into open leak channels. EMBO J 25, 5864-5872.
178. + channel, TRESK, is localized in the spinal cord. J Biol Chem 278, 27406-27412.
179. 2P10.1 (TREK-2) by the amino-terminus: role of alternative translation initiation. J Physiol 586, 5651-5663.
180. Talley EM & Bayliss DA (2002). Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action. J Biol Chem 277, 17733-17742.
181. 2P2.1 potassium channels permeable to sodium. Neuron 58, 859-870.
182. Tulleuda A, Cokic B, Callejo G, Saiani B, Serra J & Gasull X (2011). TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury. Mol Pain 7, 30.
183. Veale EL, Hassan M, Walsh Y, Al-Moubarak E & Mathie A (2014). Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome. Mol Pharmacol 85, 397-407.
184. Veale EL, Rees KA, Mathie A & Trapp S (2010). Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain. J Biol Chem 285, 29295-29304.
185. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C & Feinmark SJ (2008). TREK-1 is a novel molecular target in prostate cancer. Cancer Res 68, 1197-1203.
186. + current is limited by retention in intracellular compartments. Front Cell Neurosci 7, 246.
187. +channel-deficient mice reveals a mechanism for stabilizing bicarbonate transport. Proc Natl Acad Sci U S A 101, 8215-8220.
188. Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S & Wulff H (2005). International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 57, 463-472.
189. 2P) channels in cancer. PLoS ONE 8, e74589.
190. Woo DH, Han K-S, Shim JW, Yoon B-E, Kim E, Bae JY, Oh S-J, Hwang EM, Marmorstein AD, Bae YC, Park J-Y & Lee CJ (2012). TREK-1 and Best1 channels mediate fast and slow glutamate release in astrocytes upon GPCR activation. Cell 151, 25-40.
191. 2P channel KCNK7 does not alter volatile anesthetic sensitivity. Behav Brain Res 193, 192-196.
192. + channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins. J Physiol 587, 929-952.